✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Mesoblast Limited

Common Name
Mesoblast
Country
Australia
Sector
Healthcare
Industry
Biotechnology
Employees
81
Ticker
MSB
Exchange
Australian Securities Exchange
Description
Mesoblast Limited is a biotechnology company specializing in the development of allogeneic, or off-the-shelf, cellular medicines intended for the treatment of severe and life-threatening inflammatory ...

Disclosures of Mesoblast

Explore Mesoblast's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Mesoblast's official channels and fully traceable to its official company sources.

The table below lists all of Mesoblast's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20261 disclosure
20-F
en
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?